| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/23/2001 | US20010016955 Isolating mRNA from ripening blackcurrant fruit, preparing a cDNA library from isolated mRNA, differentially screening the library to identify gene expressed during ripening periiod and screening a genomic libray with pbrobes |
| 08/23/2001 | US20010016954 A nucleic acid comprising a promoter capable of directing expression predominantly in the roots of a plant, controls expression of a gene that does'nt respond to pathogenic infection and a sequence which encodes anti-nematode protein |
| 08/23/2001 | US20010016952 Pathogenesis of cardiomyopathy |
| 08/23/2001 | US20010016951 A recombinant DNA construct comprising a polynucleotide encoding a human Amyloid precursor protein polypeptide comprising the Swedish mutation, functionally linked to a Thy-1 promoter element which is a rodent, e.g. mouse |
| 08/23/2001 | US20010016651 Enhancing the expression of down-regulated polynucleotides or introducing down-regulated polypeptide or protein to cell can decrease the growth and/or abnormal characteristics of cancer and dysplasia |
| 08/23/2001 | US20010016650 A specific polynucleotide comprising the nucleotide sequence of protein coding sequence of clone AK647 deposited under ATCC 98026; administering to a mammal an antibody reacted to the protein for promoting smooth muscle cell growth |
| 08/23/2001 | US20010016649 Nucleic acids and polypeptides; for diagnosing chondrosarcoma and for drug screening |
| 08/23/2001 | US20010016648 Of given amino acid sequence; for diagnosis, drug screening, producing antibodies; treating autoimmune disorders |
| 08/23/2001 | US20010016647 29 human secreted proteins |
| 08/23/2001 | US20010016646 Osteogenic protein, matrix of nonsynthetic, nonpolymeric material and a binding agent |
| 08/23/2001 | US20010016644 Protein of given molecular weight and given N-terminal amino acid sequence |
| 08/23/2001 | US20010016643 Peptide derivatives |
| 08/23/2001 | US20010016355 Genetic engineering |
| 08/23/2001 | US20010016352 Oligonucleotides; detection cancer |
| 08/23/2001 | US20010016349 Mutant Neisseria; culture product |
| 08/23/2001 | US20010016341 Centrifuging, concentration |
| 08/23/2001 | US20010016340 Antihemophilia agent |
| 08/23/2001 | US20010016339 Pancreatic polypeptide |
| 08/23/2001 | US20010016338 DNA molecule encoding a variant alpha2B-adrenoceptor protein, and uses thereof |
| 08/23/2001 | US20010016337 Molecular cloning of a galanin like 7TM receptor (AXOR40) |
| 08/23/2001 | US20010016336 Genetic engineered polypeptide |
| 08/23/2001 | US20010016335 Isolated nucleic acid |
| 08/23/2001 | US20010016334 Polypeptide; screening for bactericides |
| 08/23/2001 | US20010016324 Enzymatic splitting |
| 08/23/2001 | US20010016319 Cloning of a novel G-protein coupled 7TM Receptor |
| 08/23/2001 | US20010016200 Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor |
| 08/23/2001 | US20010016199 Alphavirus RNA replicon systems |
| 08/23/2001 | US20010016198 T cell receptor ligands and methods of using same |
| 08/23/2001 | US20010016194 Compounds that inhibit the binding of raf-1 or 14-3-3 proteins to the beta chain of il-2 receptor, and pharmaceutical compositions containing same |
| 08/23/2001 | US20010016192 An expression vector of partial or total deletion of a protein DNA and a gene encoding a foreign protein; used as tumor suppressor genes |
| 08/23/2001 | US20010016191 Viewing informatoin, selecting a site for, and preparing a molecule of an alteration on a granulocyte colony-stimulating factor (g-csf) three dimensional molecule, and testing for desired characteristics; retain internal core helices |
| 08/23/2001 | DE10007468A1 Neues zentralnervöses Protein, das K·+·-Ströme moduliert New central nervous protein that modulates K · · + currents |
| 08/23/2001 | DE10006175A1 Isoform of neuregulin-beta with acidic isoelectric point, useful as indicator or target, e.g. in screening for potential neurological agents |
| 08/23/2001 | DE10005932A1 Peptide und Verfahren zur Diagnostik von Zöliakie und Dermatitis Peptides and methods for the diagnosis of celiac disease and dermatitis |
| 08/23/2001 | CA2405714A1 Radiolabeled vasoactive intestinal peptide analogs for diagnosis and radiotherapy |
| 08/23/2001 | CA2405689A1 Vasoactive intestinal peptide analogs |
| 08/23/2001 | CA2402440A1 Aids ancestral viruses and vaccines |
| 08/23/2001 | CA2400981A1 Novel proteins and novel genes encoding the same |
| 08/23/2001 | CA2400605A1 Process for extracting single-cell protein material from methanotrophic bacteria |
| 08/23/2001 | CA2400495A1 Use of opri lipoprotein from pseudomonas as a th1 inducing natural adjuvant for heterologous antigens |
| 08/23/2001 | CA2400473A1 Her-2 binding antagonists |
| 08/23/2001 | CA2400390A1 Methods for identifying signalling molecules |
| 08/23/2001 | CA2400360A1 Polypeptides and nucleic acids encoding same |
| 08/23/2001 | CA2400355A1 Pancreatic islet cell growth factors |
| 08/23/2001 | CA2400342A1 Transgenic animal model for obesity expressing foxc2 |
| 08/23/2001 | CA2400332A1 Polypeptides and nucleic acids encoding same |
| 08/23/2001 | CA2400328A1 Methods for identifying agents that cause a lethal phenotype, and agents thereof |
| 08/23/2001 | CA2400277A1 Novel peptides and methods of use |
| 08/23/2001 | CA2400263A1 Method of controlling telomere length |
| 08/23/2001 | CA2400256A1 Compositions useful for regulating parkin gene activity |
| 08/23/2001 | CA2399757A1 Polypeptoid pulmonary surfactants |
| 08/23/2001 | CA2399705A1 Treatment for bone disorders |
| 08/23/2001 | CA2399668A1 Cationic, amphipathic beta-sheet peptides and uses thereof |
| 08/23/2001 | CA2399137A1 Alteration of growth and adaptation under hypoxic conditions |
| 08/23/2001 | CA2398872A1 Avirulent, immunogenic flavivirus chimeras |
| 08/23/2001 | CA2398861A1 Gene disruption methodologies for drug target discovery |
| 08/23/2001 | CA2398825A1 Gtpase activating proteins |
| 08/23/2001 | CA2398628A1 5ht3 receptors of nematodes, polynucleotide molecules encoding same, andantagonists thereof |
| 08/23/2001 | CA2398603A1 Fibroblast growth factor-23 molecules and uses thereof |
| 08/23/2001 | CA2398395A1 Conjugates targeted to target receptors |
| 08/23/2001 | CA2396793A1 Uses of agonists and antagonists to modulate activity of tnf-related molecules |
| 08/23/2001 | CA2337574A1 Hematopoietic stem cell expansion enhancing factor and method of use |
| 08/22/2001 | EP1126034A2 Coding sequences of the human BRCA1 gene |
| 08/22/2001 | EP1126029A1 Novel g protein-coupled receptor proteins and dnas thereof |
| 08/22/2001 | EP1126028A1 Novel g protein-coupled receptor proteins, dnas thereof and ligands to the same |
| 08/22/2001 | EP1126027A1 Cell death inhibition by the caspase-12 activation inhibitor MAGE-3 |
| 08/22/2001 | EP1125948A1 Monocyte chemotactic protein-4 |
| 08/22/2001 | EP1125947A1 HUMAN H37 PROTEINS AND cDNAS ENCODING THE SAME |
| 08/22/2001 | EP1125135A2 A complex of a chaperone with -amyloid and methods employing this complex |
| 08/22/2001 | EP1124989A1 Method for determining cancer by determining expression of mage-10 |
| 08/22/2001 | EP1124988A1 Methods of identifying and characterizing mutations within bacterial dna gyrase and fabi |
| 08/22/2001 | EP1124985A1 Biomarkers for oxidative stress |
| 08/22/2001 | EP1124984A1 Host cells expressing recombinant human erythropoietin |
| 08/22/2001 | EP1124983A1 Method for producing in vivo proteins chemically diversified by incorporating non-standard amino acids |
| 08/22/2001 | EP1124977A1 Modified adenoviral fibre and uses thereof |
| 08/22/2001 | EP1124974A2 Hypersensitive response elicitor-induced stress resistance |
| 08/22/2001 | EP1124972A1 VECTOR FOR THE TRANSFORMATION OF $i(PHAFFIA RHODOZYMA) AND PROCESS OF TRANSFORMATION THEREBY |
| 08/22/2001 | EP1124967A1 PLANT-OPTIMIZED POLYNUCLEOTIDES ENCODING APPROXIMATELY 15 kDa AND APPROXIMATELY 45 kDa PESTICIDAL PROTEINS |
| 08/22/2001 | EP1124966A1 $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF |
| 08/22/2001 | EP1124965A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 08/22/2001 | EP1124964A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 08/22/2001 | EP1124963A2 Disease resistance factors |
| 08/22/2001 | EP1124962A1 Maize kin17 orthologues and uses thereof |
| 08/22/2001 | EP1124961A2 Thrombopoietic compounds |
| 08/22/2001 | EP1124960A2 Activity dependent neurotrophic factor iii (adnf iii) |
| 08/22/2001 | EP1124959A1 Cell surface molecule-induced macrophage activation |
| 08/22/2001 | EP1124958A2 Corticosteroid synthesis-associated genes |
| 08/22/2001 | EP1124957A1 Pholasin |
| 08/22/2001 | EP1124956A2 Pharmaceutical composition, containing fragments of an antigenic protein encoding dna endowed with anti-tumor effect |
| 08/22/2001 | EP1124955A1 CDNA SEQUENCE AND GENOMIC ORGANIZATION FOR A 59.4 KDA NEURONAL-SPECIFIC 7 TRANSMEMBRANE PROTEIN (pNEU60) |
| 08/22/2001 | EP1124954A2 Scorpion toxins |
| 08/22/2001 | EP1124953A2 New transcription factor of mhc class ii genes, substances capable of inhibiting this new transcription factor and medical uses of these substances |
| 08/22/2001 | EP1124952A2 Therapeutic antiangiogenic endostatin compositions |
| 08/22/2001 | EP1124951A2 Human sorting nexins |
| 08/22/2001 | EP1124941A1 Process for recovering heterologous polypeptides from bacterial cells |
| 08/22/2001 | EP1124855A2 Compositions and methods for treating polycystic kidney disease |
| 08/22/2001 | EP1124852A1 Lysine-rich statherin protein |
| 08/22/2001 | EP1124851A1 Hnovilr |
| 08/22/2001 | EP1124850A1 12 human secreted proteins |
| 08/22/2001 | EP1124849A2 Chlamydia 98kd putative outer membrane protein and corresponding dna fragments and uses thereof |